News Buzz: Gilead Sciences Inc. (NASDAQ:GILD), Goldcorp Inc. (NYSE:GG), Remy International, Inc. (NASDAQ:REMY), Union Pacific Corporation (NYSE:UNP), DryShips, Inc. (NASDAQ:DRYS)

Gilead Sciences Inc. (NASDAQ:GILD) announced the pricing of senior unsecured notes in an aggregate principal amount of $4 billion, in an underwritten, registered public offering, consisting of three tranches: $500 million of 2.350% senior notes maturing in February 2020; $1,750 million of 3.500% senior notes maturing in February 2025 and $1,750 million of 4.500% senior notes maturing in February 2045. Gilead Sciences Inc. (NASDAQ:GILD) belongs … Continue reading News Buzz: Gilead Sciences Inc. (NASDAQ:GILD), Goldcorp Inc. (NYSE:GG), Remy International, Inc. (NASDAQ:REMY), Union Pacific Corporation (NYSE:UNP), DryShips, Inc. (NASDAQ:DRYS)

Morning Watch List: Gilead Sciences Inc. (NASDAQ:GILD), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Planar Systems Inc. (NASDAQ:PLNR), Grupo Financiero Santander Mexico (NYSE:BSMX), ULTA

Merck & Co. won’t move forward with an ultra-short hepatitis C regimen that attempted to cut treatment durations in half by combining two of its drugs with another from Gilead Sciences Inc. (NASDAQ:GILD). Gilead Sciences Inc. (NASDAQ:GILD) belongs to Healthcare sector. Its net profit margin is 45.40% and weekly performance is -4.96%. On last trading day company shares ended up $106.45. Gilead Sciences Inc. (NASDAQ:GILD) … Continue reading Morning Watch List: Gilead Sciences Inc. (NASDAQ:GILD), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Planar Systems Inc. (NASDAQ:PLNR), Grupo Financiero Santander Mexico (NYSE:BSMX), ULTA

Eye Catching Stocks : Celgene Corporation (NASDAQ:CELG), Bankrate, Inc. (NYSE:RATE), China Ming Yang Wind Power Group Limited (NYSE:MY), GILD, AxoGen, Inc. (NASDAQ:AXGN)

On Oct 20, Sequenta, Inc., announced an equity investment by Celgene Corporation (NASDAQ:CELG) and other strategic investors. This financing, in addition to funding secured from several other strategic investors, will support incorporation of the ClonoSIGHT™ minimal residual disease (MRD) test into clinical trials of medicines in development for various hematological malignancies (blood cancers) and development of new clinical diagnostics based on Sequenta’s revolutionary LymphoSIGHT™ platform. … Continue reading Eye Catching Stocks : Celgene Corporation (NASDAQ:CELG), Bankrate, Inc. (NYSE:RATE), China Ming Yang Wind Power Group Limited (NYSE:MY), GILD, AxoGen, Inc. (NASDAQ:AXGN)

Watch List: Digimarc Corporation (NASDAQ:DMRC), Autohome (NYSE:ATHM), Gilead Sciences (NASDAQ:GILD), Comtech Telecommunications Corp. (NASDAQ:CMTL), Heron Therapeutics, Inc. (NASDAQ:HRTX)

Digimarc Corp. (NASDAQ:DMRC) CEO Bruce L. Davis sold 5,000 shares of Digimarc Corp. stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $24.66, for a total transaction of $123,300.00. Following the completion of the sale, the chief executive officer now directly owns 5,000 shares of the company’s stock, valued at approximately $123,300.  Digimarc Corporation (NASDAQ:DMRC) belongs to Technology … Continue reading Watch List: Digimarc Corporation (NASDAQ:DMRC), Autohome (NYSE:ATHM), Gilead Sciences (NASDAQ:GILD), Comtech Telecommunications Corp. (NASDAQ:CMTL), Heron Therapeutics, Inc. (NASDAQ:HRTX)

Stocks to Watch : Gilead Sciences Inc. (NASDAQ:GILD), Sprint (NYSE:S), DWSN, Prana Biotechnology Limited (NASDAQ:PRAN), Lime Energy (NASDAQ:LIME)

Gilead Sciences (NASDAQ:GILD) CFO Robin L. Washington sold 33,556 shares of the stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $95.56, for a total transaction of $3,206,611.36. Following the completion of the sale, the chief financial officer now directly owns 49,832 shares of the company’s stock, valued at approximately $4,761,946. The sale was disclosed in a filing with the … Continue reading Stocks to Watch : Gilead Sciences Inc. (NASDAQ:GILD), Sprint (NYSE:S), DWSN, Prana Biotechnology Limited (NASDAQ:PRAN), Lime Energy (NASDAQ:LIME)